Federico Nichetti

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data

Margherita Rimini, Lorenzo Fornaro, Sara Lonardi et al. · Liver International · 2023 · 110 citations · Full text

Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients

Federico Nichetti, Francesca Ligorio, Emma Zattarin et al. · Cancers · 2019 · 64 citations · Full text

Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program

Arsela Prelaj, Achille Bottiglieri, Claudia Proto et al. · European Journal of Cancer · 2021 · 57 citations

Advanced Nsclc, Genetic Disorder, Medicine +9

Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program

Chiara Cremolini, Daniele Rossini, Erika Martinelli et al. · The Oncologist · 2018 · 56 citations · Full text

Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation

Federica Morano, Salvatore Corallo, Monica Niger et al. · Annals of Oncology · 2018 · 37 citations · Full text